New Delhi, May 13 (PTI) Drug firm Alembic on Tuesday said its consolidated net profit increased 14 per cent to Rs 24 crore in the fourth quarter ended March 31, 2025.

The company reported a net profit of Rs 21 crore during the same quarter of FY24.

Also Read | PF Balance Check: EPFO Website Not Working? Know Your PF Balance With Just a Missed Call or SMS, Here's How.

Revenue from operations rose to Rs 60 crore in the March quarter against Rs 49 crore in the year-ago period, Alembic said in a regulatory filing.

For FY25, the company posted a net profit of Rs 145 crore as compared to Rs 93 crore in FY24.

Also Read | What Is Operation Keller? All You Need To Know About New Offensive As Indian Army Kills 3 'Hardcore' LeT Terrorists in Jammu and Kashmir's Shopian District.

Revenue increased to Rs 222 crore last fiscal over Rs 157 crore in 2023-24 fiscal.

Shares of Alembic on Tuesday ended 0.27 per cent higher at Rs 104.63 apiece on the BSE.

(This is an unedited and auto-generated story from Syndicated News feed, LatestLY Staff may not have modified or edited the content body)